Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence "SCIENCE"


Phase N/A Results N/A

Summary of Purpose

Clopidogrel besylate (CB) is not differentiated relative to the orignal clopidogrel hydrogen sulfate (CHS) in the pharmacokinetics and in antiplatelet potency in healthy volunteers. In addition,CB exhibits similar pharmacodynamic properties compared to CHS in patients with a history of acute coronary syndrome (ACS) and in patients with ACS undergoing percutaneous coronary intervention (PCI). However, there is a...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 December 2015.

1 Oct 2012 28 Apr 2014 1 May 2014 1 Nov 2014 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Perspective: Prospective
  • Sampling: Non-Probability Sample